1 马淑芳,杜志坡. 桥本甲状腺炎的诊治进展[J]. 中国医药指南,2012,10(7):77-78. 2 王雪艳,张丽芬,李卢韫. 桥本甲状腺炎诊断中测定Tg-Ab,Tm-Abd的临床价值[J]. 中国医药指南,2012,10(21):110-111. 3 朱梅,陶存武,许建宁,等.血清TG-Ab、TPO-Ab在甲状腺疾病中的应用价值[J].临床输血与检验,2012,14(2):135-137. 4 赵家军,杨利波. 甲状腺功能减退与血脂异常[J].中国实用内科杂志,2004,34(4):340-343. 5 Xu C,Yang X,Liu W,et al.Thyroid stimulating hormone,independent of thyroid hormone,can elevate the serum total cholesterol level in patients with coronary heart disease:a cross-sectional design[J].Nutr Metab(Lond),2012,9(1):44. 6 Wang F,Tan Y,Wang C,et al.Thyroid stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones[J].J Clin Endocrinol Metab,2012,97(8):2724-2731. 7 魏子坤. 提高对血清促甲状腺激素正常范围的认识[J].放射免疫学杂志,2009,22(1):120-121. 8 滕卫平 .对血清促甲状腺激素正常范围的新认识[J].中华内科杂志,2006,45(2):89-90. 9 张淑萍,张志利. 浅论促甲状腺素正常值的参考范围[J].山西医药杂志,2006,35(3):228-230. 10 张坚力.甲亢患者贫血有关指标检测分析[J].中国误诊学杂志,2008,8(31):7587-7588 . 11 李炳芝. 甲状腺功能减退性贫血者骨髓象及血象分析[J].检验医学与临床,2008,5(8):465-466. 12 Wajinrajch MP,Gertner JM,Huma Z,et al.Evaluation of growth and hormonal status in patients referred to the international fanconi anemia registry[J].Pedobiologia,2001,107(4):744-748. 13 Diez S,Banias H,Diez JL,et al.Apparent cure of Graves-Basedow Disease after sibling aiiogeneic bone marrow transplantation[J].Clinical Chemistry,1999,50(2):267-270. 14 陆再英,钟南山.内科学[M].第 7版.北京:人民卫生出版社,2009:727-728. |